Hepatitis B Virus News and Research

RSS

Research shows how the hepatitis D virus copies itself

A team of researchers has discovered how one crucial step occurs in the lifecycle of the hepatitis D virus (HDV), which causes the widespread and hard to treat liver inflammation called hepatitis D. The study, which was published recently in the Journal of Virology, could help develop antiviral therapy to control this disease.

22 Dec 2019

Researchers reveal the mystery in replication cycle of hepatitis D virus

A team led by Professor Patrick Labonté at the Institut National de la Recherche Scientifique in Montreal, Canada has identified the role of a key process in the replication cycle of the hepatitis D virus, an infection that is still very difficult to cure and affects 15 to 20 million people worldwide.

19 Dec 2019

Study uncovers need to improve HCV testing rates in young people

A new study led by Boston Medical Center uncovered a need to improve testing rates for Hepatitis C Virus in young people, specifically those with documented substance use history.

10 Dec 2019

Anti-hepatitis treatment also helps improve later complications

Hepatitis C is a serious disease, but the biggest threat to someone's health is not the virus itself. Rather, it is the diseases that can result from it such as reduced liver functioning, scar tissue in the liver and potentially cirrhosis.

5 Dec 2019

Common cold virus could infect fetus via placenta

According to researchers, the common cold viruses are capable of infecting human placental cells and may thus transmit the infection to the fetus in the womb during pregnancy. The new study was published in the journal PLOS ONE, and provides the first concrete proof that this type of carriage is possible.

3 Dec 2019

Sanitization error might possibly have exposed hundreds to HIV at Indiana hospital

An Indiana hospital is in the news for all the wrong reasons. An accidental failure by one of the seven sterilization technicians working at the hospital was recently discovered. The technician failed to carry out a single step in a protocol concerning the sanitization of surgical equipment at Goshen Hospital, over a period from April 1 to September 30.

26 Nov 2019

Combination therapy shows promise for transplanting HCV-infected organs

Data from a new study presented this week at The Liver Meeting – held by the American Association for the Study of Liver Diseases – found that combination therapy with direct-acting antivirals (DAAs) and ezetimibe.

8 Nov 2019

Cancer Atlas: Progress in the fight against cancer is not only possible, but achievable

The Cancer Atlas, 3rd edition, a comprehensive global overview of cancer around the globe, concludes that progress in the fight against cancer is not only possible, but achievable.

16 Oct 2019

UC Davis researchers awarded $1.5 million NIH grant for CRISPR cancer treatment

What if, instead of killing cancer cells or cells about to become cancerous, you could deliver a repair package and fix them? UC Davis researchers have just been awarded $1.5 million from the National Institutes of Health to start work towards that goal.

3 Oct 2019

HCV-infected donor kidneys are safe and functional one year post-transplantation

A recent analysis reveals that kidneys from donors infected with hepatitis C virus are now routinely used in transplants at many U.S. centers, and they are functioning well one year after transplantation.

13 Sep 2019

Breakthrough study shows transplanting Hepatitis C-infected kidneys is safe

Hepatitis C is a viral infection that affects the liver and is usually acquired from infected blood. Formerly called non-A, non-B hepatitis, this infection causes inflammation of the liver, sometimes causing serious liver damage.

2 Sep 2019

Needle stick injuries are common and can transmit many blood-borne pathogens

Needle stick injuries (NSIs) can transmit more than 20 blood-borne pathogens, including HIV, hepatitis B virus (HBV), hepatitis C virus (HCV) and, more rarely, malaria, human T cell leukemia virus and Ebola.

25 Aug 2019

Human apolipoprotein E promotes hepatitis B virus infection

Human apolipoprotein E (apoE) promotes hepatitis B virus (HBV) infection and production, according to a study published DATE in the open-access journal PLOS Pathogens by Luhua Qiao and Guangxiang (George) Luo of the University of Alabama at Birmingham School of Medicine.

From PLOS ONE 13 Aug 2019

Antiviral drugs for hepatitis C reduce liver-related deaths by nearly half, study shows

A new study from the UT Southwestern Simmons Comprehensive Cancer Center demonstrates that antiviral drugs for hepatitis C reduce liver-related deaths by nearly 50% in patients with a history of liver cancer.

10 Aug 2019

Discovery of unusual HBV in shrews offers new opportunity to better understand the disease

The discovery of an unusual hepatitis B virus from shrews offers new opportunities of better understanding the chronic progression of the disease. International research teams were able to demonstrate that an important protein which is essential for the development of a chronic course of infection is not present in this virus.

3 Aug 2019

90% of hepatitis cases, 65% hepatitis deaths preventable by 2030

A new report by the World Health Organization (WHO) shows that 4.5 million deaths could be prevented by 2030, and 26 million beyond that, if 67 countries in the low- and middle-income bracket invest $6 billion a year towards abolishing hepatitis. Hepatitis is a completely preventable and treatable illness at present, and in fact, hepatitis C is completely curable.

29 Jul 2019

Hepatitis B Virus News and Research

Research shows how the hepatitis D virus copies itself

Researchers reveal the mystery in replication cycle of hepatitis D virus

Study uncovers need to improve HCV testing rates in young people

Anti-hepatitis treatment also helps improve later complications

Common cold virus could infect fetus via placenta

Sanitization error might possibly have exposed hundreds to HIV at Indiana hospital

Combination therapy shows promise for transplanting HCV-infected organs

Cancer Atlas: Progress in the fight against cancer is not only possible, but achievable

UC Davis researchers awarded $1.5 million NIH grant for CRISPR cancer treatment

HCV-infected donor kidneys are safe and functional one year post-transplantation

Breakthrough study shows transplanting Hepatitis C-infected kidneys is safe

Needle stick injuries are common and can transmit many blood-borne pathogens

Human apolipoprotein E promotes hepatitis B virus infection

Antiviral drugs for hepatitis C reduce liver-related deaths by nearly half, study shows

Discovery of unusual HBV in shrews offers new opportunity to better understand the disease

90% of hepatitis cases, 65% hepatitis deaths preventable by 2030

EPFL scientists create first world map of regions with highest hepatitis E prevalence

Australia leads the world in childhood immunization coverage

Molecular virologist receives nearly $2 million NIH grant renewal to study hepatitis E virus

Researcher employs people who inject drugs to study factors influencing acquisition of HIV

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News